For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Drosperinone and Ethinyl Estradiol | Drospirenone (3mg) and Ethinyl estradiol (0.02mg) (YAZ)tablet once a day | None | None | 0 | 16 | 2 | 16 | View |
| Placebo Tablet | Placebo tablet once a day | None | None | 0 | 14 | 0 | 14 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Loss of appetite | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| moodiness | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| break through bleeding | SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | None | View |